Advertisement

Index by author

June 01, 2019; Volume 47,Issue 6

  1. Miners, John O.

    1. Computational Prediction of the Site(s) of Metabolism and Binding Modes of Protein Kinase Inhibitors Metabolized by CYP3A4
      Pramod C. Nair, Ross A. McKinnon and John O. Miners
      Drug Metabolism and Disposition June 2019, 47 (6) 616-631; DOI: https://doi.org/10.1124/dmd.118.085167

  2. Mizuguchi, Hiroyuki

    1. Modeling of Hepatic Drug Metabolism and Responses in CYP2C19 Poor Metabolizer Using Genetically Manipulated Human iPS cells
      Modeling of Hepatic Drug Metabolism and Responses in CYP2C19 Poor Metabolizer Using Genetically Manipulated Human iPS cells
      Sayaka Deguchi, Tomoki Yamashita, Keisuke Igai, Kazuo Harada, Yukiko Toba, Kazumasa Hirata, Kazuo Takayama and Hiroyuki Mizuguchi
      Drug Metabolism and Disposition June 2019, 47 (6) 632-638; DOI: https://doi.org/10.1124/dmd.119.086322

  3. Nair, Pramod C.

    1. Computational Prediction of the Site(s) of Metabolism and Binding Modes of Protein Kinase Inhibitors Metabolized by CYP3A4
      Pramod C. Nair, Ross A. McKinnon and John O. Miners
      Drug Metabolism and Disposition June 2019, 47 (6) 616-631; DOI: https://doi.org/10.1124/dmd.118.085167

  4. Nakajima, Miki

    1. RNA Editing Enzymes Modulate the Expression of Hepatic CYP2B6, CYP2C8, and Other Cytochrome P450 Isoforms
      Kaori Nozaki, Masataka Nakano, Chika Iwakami, Tatsuki Fukami and Miki Nakajima
      Drug Metabolism and Disposition June 2019, 47 (6) 639-647; DOI: https://doi.org/10.1124/dmd.119.086702

  5. Nakano, Masataka

    1. RNA Editing Enzymes Modulate the Expression of Hepatic CYP2B6, CYP2C8, and Other Cytochrome P450 Isoforms
      Kaori Nozaki, Masataka Nakano, Chika Iwakami, Tatsuki Fukami and Miki Nakajima
      Drug Metabolism and Disposition June 2019, 47 (6) 639-647; DOI: https://doi.org/10.1124/dmd.119.086702

  6. Nozaki, Kaori

    1. RNA Editing Enzymes Modulate the Expression of Hepatic CYP2B6, CYP2C8, and Other Cytochrome P450 Isoforms
      Kaori Nozaki, Masataka Nakano, Chika Iwakami, Tatsuki Fukami and Miki Nakajima
      Drug Metabolism and Disposition June 2019, 47 (6) 639-647; DOI: https://doi.org/10.1124/dmd.119.086702

  7. Ogier, Julien

    1. Prediction of Human Nonlinear Pharmacokinetics of a New Bcl-2 Inhibitor Using PBPK Modeling and Interspecies Extrapolation Strategy
      Philippe B. Pierrillas, Emilie Henin, Kathryn Ball, Julien Ogier, Magali Amiel, Laurence Kraus-Berthier, Marylore Chenel, François Bouzom and Michel Tod
      Drug Metabolism and Disposition June 2019, 47 (6) 648-656; DOI: https://doi.org/10.1124/dmd.118.085605

  8. Orwin, Michael C.

    1. Rolapitant Is a Reversible Inhibitor of CYP2D6
      Sarah M. Glass, Sabrina M. Leddy, Michael C. Orwin, Garret P. Miller, Kyle A. Furge and Laura Lowe Furge
      Drug Metabolism and Disposition June 2019, 47 (6) 567-573; DOI: https://doi.org/10.1124/dmd.118.085928

  9. Pierrillas, Philippe B.

    1. Prediction of Human Nonlinear Pharmacokinetics of a New Bcl-2 Inhibitor Using PBPK Modeling and Interspecies Extrapolation Strategy
      Philippe B. Pierrillas, Emilie Henin, Kathryn Ball, Julien Ogier, Magali Amiel, Laurence Kraus-Berthier, Marylore Chenel, François Bouzom and Michel Tod
      Drug Metabolism and Disposition June 2019, 47 (6) 648-656; DOI: https://doi.org/10.1124/dmd.118.085605

  10. Qian, Chaoqun

    1. Impairment of Intestinal Monocarboxylate Transporter 6 Function and Expression in Diabetic Rats Induced by Combination of High-Fat Diet and Low Dose of Streptozocin: Involvement of Butyrate–Peroxisome Proliferator-Activated Receptor-γ Activation
      Feng Xu, Liang Zhu, Chaoqun Qian, Junjie Zhou, Donghao Geng, Ping Li, Wenjing Xuan, Fangge Wu, Kaijing Zhao, Weimin Kong, Yuanyuan Qin, Limin Liang, Li Liu and Xiaodong Liu
      Drug Metabolism and Disposition June 2019, 47 (6) 556-566; DOI: https://doi.org/10.1124/dmd.118.085803
« Previous (Pages : 2 3 4 5 6 7 8 9 10 ... 10) Next »
Back to top

In this issue

Advertisement